OCEANIC SA has been present on the market for over 30 years with its unique global philosophy of creating products for people with sensitive skin prone to allergies. As one of the leaders of the Polish cosmetics market, we are present with our products both on the modern and traditional market. At the same time, we strengthen our presence on the pharmaceutical market through the offer of cosmetics, medicines and medical devices, and on the professional market through preparations dedicated to cosmetic institutes and SPA salons. Our products can be found on shelves in more than 30 countries around the world on 4 continents.
46.45.Z - Wholesale of perfume and cosmetics
10 - Manufacture of food products
11 - Manufacture of beverages
20 - Manufacture of chemicals and chemical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46 - Wholesale trade, except of motor vehicles and motorcycles
47 - Retail trade, except motor vehicle retail
58 - Publishing activities
62 - Computer programming, consultancy and related activities
64.19 - Other monetary intermediation
64.2 - Activities of holding companies
64.3 - Trusts, funds and similar financial entities
64.9 - Other financial service activities, except insurance and pension funding
68 - Real estate activities
70 - Activities of head offices; management consultancy activities
71 - Architectural and engineering activities; technical testing and analysis
72 - Scientific research and development
73 - Advertising and market research
96 - Other personal service activities
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Net sales | 228,3 | 225,7 | 211,5 | -6,3 |
Liabilities and provisions | 139,1 | 125,4 | 128,8 | 2,7 |
Equity | 126,1 | 130,6 | 115,6 | -11,5 |
Total assets | 265,2 | 256 | 244,4 | -4,5 |
Cash and cash equivalents | 5 | 11,7 | 3,8 | -67,7 |
Depreciation | 6 | 6 | 5,4 | -10,1 |
Gross profit / loss | 27,5 | 13,1 | -7,6 | -158,1 |
EBITDA | 35,5 | 20,9 | 3,4 | -83,8 |
Net profit / loss | 18,9 | 10,9 | -6,7 | -161,8 |
Operating profit (EBIT) | 29,5 | 14,9 | -2 | -113,4 |
Current assets | 91,7 | 89,6 | 79,1 | -11,8 |
% | % | % | p.p. | |
Return on equity (ROE) | 15 | 8,4 | -5,8 | -14,2 |
Return on sales (ROS) | 8,3 | 4,8 | -3,2 | -8 |
Equity ratio | 47,5 | 51 | 47,3 | -3,7 |
EBITDA margin | 15,6 | 9,2 | 1,6 | -7,6 |
Gross profit margin | 12 | 5,8 | -3,6 | -9,4 |
Days | Days | Days | Days | |
Current liabilities turnover ratio | 84 | 84 | 88 | 4 |
Current ratio | 1,7 | 1,7 | 1,5 | -0,2 |
Net debt to EBITDA | 2,2 | 2,9 | 21,4 | 18,5 |
Opinions regarding services, products, and company activities are not verified. This means that ING Services for Business S.A., as the provider of the Aleo platform, does not ensure that the published opinions come from consumers who have used the product or availed of the company's services. However, we do strive to ensure that opinions do not violate universally applicable laws.